Patent · US Expired

Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1&agr;, 25-dihydroxy vitamin D3

US6380408B1 · kind B1 · utility

40Cited by
13References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2000
Grant dateApr 30, 2002
Priority date
Expiry dateMar 31, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel sulfur-containing analogs of 1&agr;,25-dihydroxy vitamin D3 are provided. These analogs are synthesized in a convergent manner by joining A-ring and C,D ring fragments. Each analog with 1&agr;,3&bgr;-substituent stereochemistry shows a pharmacologically desirable combination of high antiproliferative and high transcriptional activities in vitro and also low calcemic activity in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.